On-site pathology tests for infectious diseases in rural and remote locations can be just as reliable and accurate as tests carried out in a hospital laboratory, a new report shows. On-site pathology ...

Molecular testing in routine surgical pathology is becoming an important component of the workup of many different types of tumors. In fact, in some organ systems, guidelines now suggest that the ...

Anyone who has endured a COVID-19 test and then counted down the hours until the results arrived knows how important it is to the patient to shrink the wait, and reduce anxiety and time in ...

The University of Alabama at Birmingham School of Medicine and UAB Hospital laboratories have established the Genomic Diagnostics Lab, a first step toward an expanded offering of genomic diagnostic ...

Fulgent Genetics, Inc. FLGT recently entered into an agreement to acquire selected assets of Bako Diagnostics and to acquire StrataDx — two well-known pathology testing companies — in a combined ...

Laboratory tests play a critical part of the healthcare system. Ordering and billing for these tests, however, is not always cut-and-dry. Compliance with federal laws and rules (like the Clinical ...

In a recent study published in Nature Communications, researchers establish AnimalGAN as a reliable alternative for generating synthetic pathology data in an effort to ultimately reduce animal testing ...

Affinity Technologies, Inc. (NASDAQ:BIAF) released its financial results for the year ended December 31, 2025, according to a ...

The Dubbo community will benefit from an $8.2 million investment by the Minns Labor Government to deliver major upgrades to NSW Health Pathology’s laboratory at Dubbo Health Service.

BRISBANE, Australia: Integrated drone logistics networks will soon be shuttling pathology samples from the Moreton Bay islands to Mater Pathology testing labs under a new partnership between Mater and ...

Proposed acquisition will add new anatomic pathology services, proprietary PCR tests and a national client base EL MONTE, Calif., December 22, 2025--(BUSINESS WIRE)--Fulgent Genetics, Inc. (NASDAQ: ...